ID: ALA5268473

Max Phase: Preclinical

Molecular Formula: C18H16BrNO4

Molecular Weight: 390.23

Associated Items:

Representations

Canonical SMILES:  COc1cccc(OC)c1NC(=O)C1=Cc2c(Br)cccc2OC1

Standard InChI:  InChI=1S/C18H16BrNO4/c1-22-15-7-4-8-16(23-2)17(15)20-18(21)11-9-12-13(19)5-3-6-14(12)24-10-11/h3-9H,10H2,1-2H3,(H,20,21)

Standard InChI Key:  PCTOQJUKXUIDBG-UHFFFAOYSA-N

Associated Targets(non-human)

PC-12 7051 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 390.23Molecular Weight (Monoisotopic): 389.0263AlogP: 3.88#Rotatable Bonds: 4
Polar Surface Area: 56.79Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.30CX Basic pKa: CX LogP: 3.50CX LogD: 3.50
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.86Np Likeness Score: -0.34

References

1. Chen X, Zhu H, Liu X, Li Q, Dong M..  (2023)  Design and synthesis of novel GluN2A NMDAR positive allosteric modulators via scaffold hopping strategy as anti-stroke therapeutic agents.,  83  [PMID:36934527] [10.1016/j.bmc.2023.117236]

Source